亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Peripheral nerve block anesthesia/analgesia for patients undergoing primary hip and knee arthroplasty: recommendations from the International Consensus on Anesthesia-Related Outcomes after Surgery (ICAROS) group based on a systematic review and meta-analysis of current literature

医学 科克伦图书馆 关节置换术 麻醉 随机对照试验 荟萃分析 梅德林 系统回顾 观察研究 外科 内科学 政治学 法学
作者
Stavros G. Memtsoudis,Crispiana Cozowicz,Janis Bekeris,Dace Bekere,Jiabin Liu,Ellen M. Soffin,Edward R. Mariano,Rebecca L. Johnson,George Go,Mary J. Hargett,Bradley H. Lee,Pamela Wendel,Mark Brouillette,Sang Jo Kim,Lila Baaklini,Douglas S. Wetmore,Genewoo Hong,Rie Goto,Bridget Jivanelli,Vassilis Athanassoglou
出处
期刊:Regional Anesthesia and Pain Medicine [BMJ]
卷期号:46 (11): 971-985 被引量:147
标识
DOI:10.1136/rapm-2021-102750
摘要

Background Evidence-based international expert consensus regarding the impact of peripheral nerve block (PNB) use in total hip/knee arthroplasty surgery. Methods A systematic review and meta-analysis: randomized controlled and observational studies investigating the impact of PNB utilization on major complications, including mortality, cardiac, pulmonary, gastrointestinal, renal, thromboembolic, neurologic, infectious, and bleeding complications. Medline, PubMed, Embase, and Cochrane Library including Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, NHS Economic Evaluation Database, were queried from 1946 to August 4, 2020. The Grading of Recommendations Assessment, Development, and Evaluation approach was used to assess evidence quality and for the development of recommendations. Results Analysis of 122 studies revealed that PNB use (compared with no use) was associated with lower ORs for (OR with 95% CIs) for numerous complications (total hip and knee arthroplasties (THA/TKA), respectively): cognitive dysfunction (OR 0.30, 95% CI 0.17 to 0.53/OR 0.52, 95% CI 0.34 to 0.80), respiratory failure (OR 0.36, 95% CI 0.17 to 0.74/OR 0.37, 95% CI 0.18 to 0.75), cardiac complications (OR 0.84, 95% CI 0.76 to 0.93/OR 0.83, 95% CI 0.79 to 0.86), surgical site infections (OR 0.55 95% CI 0.47 to 0.64/OR 0.86 95% CI 0.80 to 0.91), thromboembolism (OR 0.74, 95% CI 0.58 to 0.96/OR 0.90, 95% CI 0.84 to 0.96) and blood transfusion (OR 0.84, 95% CI 0.83 to 0.86/OR 0.91, 95% CI 0.90 to 0.92). Conclusions Based on the current body of evidence, the consensus group recommends PNB use in THA/TKA for improved outcomes. Recommendation: PNB use is recommended for patients undergoing THA and TKA except when contraindications preclude their use. Furthermore, the alignment of provider skills and practice location resources needs to be ensured. Evidence level: moderate; recommendation: strong.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
羞涩的烨华完成签到,获得积分10
3秒前
8秒前
18秒前
19秒前
26秒前
花海完成签到,获得积分10
26秒前
花海发布了新的文献求助30
29秒前
Benhnhk21完成签到,获得积分10
31秒前
34秒前
在水一方应助笑点低剑封采纳,获得10
41秒前
41秒前
冷酷的冰枫完成签到,获得积分10
42秒前
大个应助水长聿采纳,获得10
43秒前
45秒前
49秒前
Kao应助科研通管家采纳,获得10
50秒前
52秒前
阿志完成签到,获得积分10
1分钟前
1分钟前
朴素的语兰完成签到,获得积分10
1分钟前
1分钟前
2分钟前
2分钟前
心想柿橙完成签到,获得积分10
2分钟前
棠臻完成签到 ,获得积分10
2分钟前
水长聿完成签到,获得积分10
2分钟前
2分钟前
水长聿发布了新的文献求助10
2分钟前
酷波er应助愉快的问凝采纳,获得10
2分钟前
2分钟前
lingling发布了新的文献求助10
2分钟前
2分钟前
nowss完成签到,获得积分10
2分钟前
Kao应助科研通管家采纳,获得10
2分钟前
Kao应助科研通管家采纳,获得10
2分钟前
Kao应助科研通管家采纳,获得10
2分钟前
2分钟前
香蕉苹果发布了新的文献求助50
3分钟前
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场现状调查及投资机会研判报告 1000
2026年中国辛酸癸酸聚乙二醇甘油酯行业市场规模及竞争格局分析报告 1000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Introducing the Learning Sciences 600
Resiliency Scale for Adolescents--Chinese Version 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7323597
求助须知:如何正确求助?哪些是违规求助? 8938947
关于积分的说明 18952061
捐赠科研通 6980770
什么是DOI,文献DOI怎么找? 3215275
关于科研通互助平台的介绍 2382675
邀请新用户注册赠送积分活动 2194516